Multidetector-Row Computed Tomography and Colour Doppler Imaging in the Evaluation of Patients with Extrahepatic Portal Hypertension: A Prospective Study

Document Type : Original Article

Authors

Department of Radiology, Sher-i-Kashmir Institute of Medical Sciences, Soura, India

Abstract

Background and aims: Evaluating patients of extrahepatic portal hypertension with Colour Doppler and MDCT to study the morphology of splenoportal axis, determining the site of obstruction, the anatomy of portosystemic collaterals, any associated vascular aneurysms, and features of portal biliopathy.
Materials and methods: We studied  45 patients (aged 6-55 years) with clinical features of portal hypertension with no identifiable hepatic cause or extrahepatic portal venous occlusion on sonography. All cases underwent Doppler ultrasound and  MDCT.  The data was compiled and analyzed. A comparative evaluation of Doppler imaging and MDCT was performed with the help of Cohen's kappa test to assess the agreement between the two modalities.
Results: MDCT provides better details about the morphology of the splenoportal axis, the site, and cause of block, as well as the extent and distribution of collateral groups. Colour Doppler has an advantage over MDCT in determining the direction and pattern of blood flow within the splenoportal axis, various collaterals, and spontaneous shunts, along with a better depiction of features of portal biliopathy. Colour Doppler is inadequate in the visualization of gastroesophageal and retroperitoneal varices. Identification of spontaneous spleno-adreno-renal and gastrorenal shunts is achieved with the high agreement between Colour Doppler and MDCT.

Conclusion: MDCT should be preferred for preoperative evaluation of patients being contemplated for shunt surgery. Colour Doppler imaging of portal biliopathy is sufficiently characteristic to avoid other invasive modalities. The two modalities provide complementary information in the evaluation of patients with extrahepatic portal hypertension.

Keywords

Main Subjects


[1]  Dilawari JB, Chawla YK. Extrahepatic portal venous obstruction. Gut. 1988;29(4):554-5. doi: 10.1136/gut.29.4.554.
[2]  Anand CS, Tandon BN, Nundy S. The causes, management and outcome of upper gastrointestinal haemorrhage in an Indian hospital. Journal of British Surgery. 1983;70(4):209-11. https://doi.org/10.1002/bjs.1800700407.
[3]  Poddar U, Thapa BR, Rao KN, Singh K. Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West?. Journal of gastroenterology and hepatology. 2008;23(9):1354-7. https://doi.org/10.1111/j.1440-1746.2007.05102.x.
[4]  WEBB LJ, SHERLOCK S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. QJM: An International Journal of Medicine. 1979;48(4):627-39. https://doi.org/10.1093/oxfordjournals.qjmed.a067598.
[5]  Cohen J, Edelman RR, Chopra S. Portal vein thrombosis: a review. The American journal of medicine. 1992;92(2):173-82. https://doi.org/10.1016/0002-9343(92)90109-O.
[6]  Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. Journal of hepatology. 2000;32(5):865-71. DOI:https://doi.org/10.1016/S0168-8278(00)80259-7.
[7]  Witte CL, Brewer ML, Witte MH, Pond GB. Protean manifestations of pylethrombosis. A review of thirty-four patients. Annals of surgery. 1985;202(2):191. doi: 10.1097/00000658-198508000-00009.
[8]  Thompson EN, SHERLOCK S. The aetiology of portal vein thrombosis with particular reference to the role of infection and exchange transfusion. QJM: An International Journal of Medicine. 1964;33(4):465-80.
[9]  Valla D, Casadevall N, Huisse MG, Tulliez M, Grange JD, Muller O, et al. Etiology of portal vein thrombosis in adults: a prospective evaluation of primary myeloproliferative disorders. Gastroenterology. 1988 Apr 1;94(4):1063-9. https://doi.org/10.1016/0016-5085(88)90567-7.
[10] Lang R, Inbal A, Jutrin I, Ravid M. Recurrent venous thrombosis: the sole manifestation of an occult myeloproliferative disease. Israel journal of medical sciences. 1982;18(6):705-7.
[11] Pirisi M, Avellini C, Fabris C, Scott C, Bardus P, Soardo G, et al. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. Journal of cancer research and clinical oncology. 1998;124(7):397-400. https://doi.org/10.1007/s004320050189.
[12] Broe PJ, Conley CL, Cameron JL. Thrombosis of the portal vein following splenectomy for myeloid metaplasia. Surgery, gynecology & obstetrics. 1981;152(4):488-92.
[13] Eguchi A, Hashizume M, Kitano S, Tanoue K, Wada H, Sugimachi K. High rate of portal thrombosis after splenectomy in patients with esophageal varices and idiopathic portal hypertension. Archives of Surgery. 1991;126(6):752-5. doi:10.1001/archsurg.1991.01410300098015.
[14] Fujita F, Lyass S, Otsuka K, Giordano L. Portal vein thrombosis following splenectomy: identification of risk factors. The American surgeon. 2003;69(11):951.
[15] Rossi P, Passariello R, Simonetti G. Portal thrombosis: high incidence following splenectomy for portal hypertension. Gastrointestinal radiology. 1976;1(1):225-7. https://doi.org/10.1007/BF02256370.
[16] Poddar U, Thapa BR, Singh K. Band ligation plus sclerotherapy versus sclerotherapy alone in children with extrahepatic portal venous obstruction. Journal of clinical gastroenterology. 2005;39(7):626-9. doi: 10.1097/01.mcg.0000170765.36825.66.
[17] Achar S, Dutta HK, Gogoi RK. Extrahepatic portal vein obstruction in children: role of preoperative imaging. Journal of Indian Association of Pediatric Surgeons. 2017;22(3):144. doi: 10.4103/0971-9261.207634.
[18] Madrazo BL, Jafri SZ, Shirkhoda A, Roberts JL, Ellwood RA. Portosystemic collaterals: evaluation with color Doppler imaging and correlation with CT and MRI. InSeminars in interventional radiology 1990;7(03)-169-184. DOI: 10.1055/s-2008-1074606.
[19] De Gaetano AM, Lafortune M, Patriquin H, De Franco A, Aubin B, Paradis K. Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography. AJR. American journal of roentgenology. 1995;165(5):1151-5. 10.2214/ajr.165.5.7572494.
[20] Arora NK, Lodha R, Gulati S, Gupta AK, Mathur P, Joshi MS, et al. Portai hypertension in North Indian children. The Indian Journal of Pediatrics. 1998;65(4):585-91. https://doi.org/10.1007/BF02730901.
[21] VALLA DC, Condat B, Lebrec D. Spectrum of portal vein thrombosis in the West. Journal of Gastroenterology and Hepatology. 2002;17:S224-7. https://doi.org/10.1046/j.1440-1746.17.s3.4.x.
[22] Dhiman RK, Behera A, Chawla YK, Dilawari JB, Suri S. Portal hypertensive biliopathy. Gut. 2007;56(7):1001-8. http://dx.doi.org/10.1136/gut.2006.103606.
[23] Adaletli I, Bariş S, Gülşen G, Kurugoglu S, Kantarci F, Mihmanli I, et al. Comparison of color doppler US and CT portography in evaluating portal hypertension in children. Southern medical journal. 2012;105(1):6-10.
[24] El-Assaly H, Metwally LI, Azzam H, Seif-Elnasr MI. A comparative study of multi-detector CT portography versus endoscopy in evaluation of gastro-esophageal varices in portal hypertension patients. Egyptian Journal of Radiology and Nuclear Medicine. 2020;51(1):1-0. https://doi.org/10.1186/s43055-019-0117-5.
[25] Nićiforović D, Till V, Vučaj-Ćirilović V, Petrović K, Juković M, Hadnađev-Šimonji D, et al. The role of the color Doppler ultrasonography and computed tomography in estimation of portal hypertension. Srpski arhiv za celokupno lekarstvo. 2016;144(11-12):602-7.  https://doi.org/10.2298/SARH1612602N.
Volume 3, Issue 2
June 2021
Pages 86-93
  • Receive Date: 21 April 2021
  • Revise Date: 05 June 2021
  • Accept Date: 22 June 2021
  • First Publish Date: 22 June 2021